NIH-funded research NIH-funded research

Low‑barrier hepatitis C care for people in jail

Official title: Implementing a Low-Threshold Hepatitis C Treatment in a Jail Setting

Funded at Rhode Island Hospital · NIH-11192887 · Data updated 2026-11-12

This project offers simple, take‑home hepatitis C medicine plus community navigation to people who inject drugs who are jailed, including those living with HIV.

More Hepatitis C research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRhode Island Hospital
NIH-funded
Lab location1 site (Providence, United States)
Project startSeptember 15, 2024
Project endAugust 31, 2027
Funding year2025
Award (this year)$235,644
NIH project number5R34DA061732-02
Project IDNIH-11192887 on NIH RePORTER

Who could benefit from this research

Could help

Adults jailed who inject drugs and have hepatitis C, with or without HIV co‑infection, would be the intended participants.

Less likely to help

People without hepatitis C, those with medical contraindications to the antiviral drugs, or those not detained in the participating jail sites would not directly benefit from this project.

What this research studies

You would be offered a short, low‑barrier hepatitis C treatment plan adapted for jails called MINMON‑J that includes take‑home antiviral pills when appropriate. The team will work with a community Transitions Clinic and community health workers to help you start treatment in jail and connect to follow‑up care after release. The project is a single‑arm pilot, meaning everyone enrolled will receive the MINMON‑J approach and staff will track treatment starts, completion, and linkage to community care. The goal is to show this approach can be delivered in fast‑turnover jail settings and support people through release.

Why it matters

Potential benefit: If successful, this approach could cure more people of hepatitis C who pass through jails and improve continuity of care after they leave custody.

How similar studies have gone: Related low‑monitoring MINMON approaches have cured HCV in other high‑risk populations, but applying this model specifically in short‑stay jails is a new adaptation.

Where this research is happening

  • Rhode Island Hospital
    Providence, United States
    Active

Researchers

  • Principal investigator: Berk, Justin — Rhode Island Hospital
  • Study coordinator: Berk, Justin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.